150 completed, 30 unknown, 20 terminated, 11 recruiting. 233 Phase 2, 31 Phase 3, 25 Phase 1.
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections | Phase 1 / Phase 2 | Withdrawn | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2026-12-31 | 2026-08-17 | |
| Platform Trial for Salvage Consolidation Therapy in Dimorphic Fungi Oteseconazole - Coccidioidomycosis, Blastomycosis | Phase 2 | Not yet recruiting | University of Minnesota | 30 | 2026-12-01 | 2026-09-04 |
| A Phase II Randomized Study to Evaluate Measures for Endpoint Derivation in Patients With Progressive or Refractory Disseminated Coccidioidomycosis Treated With Olorofim Plus Baseline Standard of Care or Placebo Plus Baseline Standard of Care Olorofim, Placebo - Coccidioidomycosis, Disseminated Fungal Infection | Phase 2 | Not yet recruiting | F2G Ltd | 50 | 2026-12-01 | 2026-09-22 |
| Safety and Efficacy Study of SKX-16 in Participants With Mild to Moderate Distal Subungual Onychomycosis SKX-16 (Luliconazole 10% Solution), Vehicle solution - Onychomycosis of Toenails | Phase 2 | Not yet recruiting | SATO Pharmaceutical Co., Ltd. | 204 | 2026-11-24 | 2026-11-10 |
| Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence OCF001 Intravaginal Gel, Placebo Gel - Candidiasis, Vulvovaginal | Phase 2 | Recruiting | Sano Chemicals Inc | 36 | 2026-06-04 | 2026-06-15 |
| Olorofim in Early Coccidioidal Meningitis olorofim - Coccidioidal Meningitis | Phase 2 | Recruiting | Fariba Donovan | 12 | 2026-06-01 | 2026-07-27 |
| Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections pathogen-specific CTLs - Pathogen Infection, EBV Infection | Phase 1 / Phase 2 | Terminated | Shenzhen Geno-Immune Medical Institute | 100 | 2026-06-01 | 2026-11-02 |
| Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Treatment of Pityriasis Versicolor Topical 1 % clotrimazole twice daily 2 weeks, Oral itraconazole 200mg daily for 5 days - Pityriasis Versicolor | Phase 1 / Phase 2 | Not yet recruiting | Combined Military Hospital Abbottabad | 86 | 2026-02-02 | 2026-01-12 |
| CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia Caspofungin Acetate 50 MG, Physiologic saline - Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection | Phase 1 / Phase 2 | Recruiting | University Hospital, Tours | 100 | 2025-12-02 | 2026-10-09 |
| Platform Trial For Cryptococcal Meningitis (PLATFORM-CM) Standard of care, Oteseconazole - antifungal therapy 1, Turletricin injection - antifungal therapy 2 - Hiv, Cryptococcal Meningitis | Phase 2 / Phase 3 | Recruiting | David Boulware | 2000 | 2025-05-28 | 2026-07-27 |
| Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis Trichostatin A - Onychomycosis of Toenail | Phase 2 | Active not recruiting | Vanda Pharmaceuticals | 50 | 2025-05-05 | 2026-02-04 |
| iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine Radiopharmaceutical: gallium-68-deferoxamine ([68Ga]Ga-DFO-B) - Pulmonary Aspergillosis, Chronic Pulmonary Aspergillosis | Phase 2 | Completed | Radboud University Medical Center | 10 | 2025-05-01 | 2026-08-18 |
| Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial genotype-directed dosing with dosing software based on therapeutic drug monitoring - Fungal Infection, Haematological Malignancy | Phase 2 | Recruiting | The University of Queensland | 104 | 2025-04-14 | 2026-04-16 |
| Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working Amphotericine in liposome (Ambisome®) - Tinea Capitis | Phase 2 / Phase 3 | Active not recruiting | Sohag University | 30 | 2025-04-01 | 2025-05-20 |
| Topical Tolnaftate Stick for Tinea Pedis: An Open-Label Interventional Study 1% Tolnaftate Stick Formula A, 1% Tolnaftate Stick Formula B, 1% Tolnaftate Stick Formula C - Tinea Pedis | Phase 2 | Recruiting | Propedix, Inc. | 150 | 2024-12-30 | 2025-11-28 |
| Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections Voriconazole high dose, Voriconazole low dose - Dermatophyte Infection | Phase 2 | Not yet recruiting | Sheikh Zayed Medical College | 120 | 2024-11-15 | 2024-11-08 |
| CelAgace™ OraRinse Solution for Treatment of Candidiasis silver citrate complex and acemannan - Candidiasis, Oral | Phase 1 / Phase 2 | Unknown | CelaCare Technologies, Inc. | 15 | 2024-09-01 | 2024-02-09 |
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection BGY-1601-VT, PLACEBO - Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | NEXBIOME THERAPEUTICS | 165 | 2024-07-08 | 2024-06-12 |
| Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection BSG005 - Invasive Fungal Infection | Phase 1 / Phase 2 | Unknown | Biosergen AS | 15 | 2024-07-01 | 2025-04-06 |
| A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis ATB1651-102- Cohort 1, ATB1651-102- Cohort 2, ATB1651-102- Cohort 3 - Onychomycosis | Phase 2 | Recruiting | AmtixBio Co., Ltd. | 120 | 2024-07-01 | 2025-02-19 |
Showing 20 of 233. Sign in to see all of them.
Onychomycosis (40) · Aspergillosis (25) · Candidiasis, Vulvovaginal (23) · Candidiasis (18) · Tinea Pedis (17) · HIV Infections (15) · Invasive Fungal Infections (14) · Aspergillosis, Allergic Bronchopulmonary (13) · Meningitis, Cryptococcal (12) · Candidiasis, Invasive (10) · Acquired Immunodeficiency Syndrome (9) · Candidemia (9) · Histoplasmosis (9) · Coccidioidomycosis (8)
Bacterial Infections and Mycoses (233) · Infections (230) · Skin Diseases, Infectious (76) · Skin and Connective Tissue Diseases (76) · Skin Diseases (75) · Dermatomycoses (74) · Tinea (59) · Genital Diseases (41) · Urogenital Diseases (41) · Nail Diseases (40) · Pathological Conditions, Signs and Symptoms (38) · Immune System Diseases (37) · Lung Diseases (37) · Respiratory Tract Diseases (37)
Fluconazole (21) · Caspofungin (20) · Itraconazole (15) · liposomal amphotericin B (13) · Amphotericin B (12) · Voriconazole (11) · Micafungin (10) · Terbinafine (8) · posaconazole (8) · Flucytosine (5) · Miconazole (5) · Standard of Care (5) · Trimethoprim, Sulfamethoxazole Drug Combination (5) · tavaborole (5) · Anidulafungin (4)
Merck Sharp & Dohme LLC (13) · Pfizer (13) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Post Graduate Institute of Medical Education and Research, Chandigarh (9) · Astellas Pharma Inc (4) · DermBiont, Inc. (4) · Matinas BioPharma Nanotechnologies, Inc. (4) · Nitric BioTherapeutics, Inc (4) · Scynexis, Inc. (4) · Viamet (4) · Basilea Pharmaceutica (3) · Novartis Pharmaceuticals (3) · Pulmocide Ltd (3) · AM-Pharma (2) · Almirall, S.A. (2)
United States (99) · Germany (23) · France (18) · Canada (15) · India (15) · United Kingdom (15) · Belgium (14) · Spain (12) · Italy (11) · Netherlands (10) · Poland (9) · South Africa (8) · Australia (7) · Israel (7) · Austria (6)
David Angulo, MD (4) · Marc Engelhardt (3) · William Dismukes (3) · Christoph Willers, MD, MBA (2) · George R Thompson, MD (2) · Kenneth Hodge, MD (2) · Phoebe Rich, MD (2) · Quyen T Nguyen, MD (2) · Ritesh Agarwal, MD, DM (2) · Sara R Botros, bachelor of clinical pharmacy (2)
PMID 36396498, PMID 41151592, PMID 15232472, PMID 16304338, PMID 16436724, PMID 16505648, PMID 16678903, PMID 18046534, PMID 18230259, PMID 18983417, PMID 19172247, PMID 19441980, PMID 19897055, PMID 20547942, PMID 20607114, PMID 20697067, PMID 20946413, PMID 21729932, PMID 21732834, PMID 21911573, PMID 21937481, PMID 21967490, PMID 22045986, PMID 22548840, PMID 23335740, PMID 23377392, PMID 23410808, PMID 23940606, PMID 24173203, PMID 24307695, PMID 25451051, PMID 25701307, PMID 26270686, PMID 26316385, PMID 26585431, PMID 26872154, PMID 26935726, PMID 27297276, PMID 29304768, PMID 29331473, PMID 29534874, PMID 29697768, PMID 29744900, PMID 30049743, PMID 30184181, PMID 30526582, PMID 30561849, PMID 30776290, PMID 30801037, PMID 31548210
2009 (5), 2019 (4), 2023 (4), 2008 (3), 2018 (3), 2017 (2), 2014 (1), 2015 (1), U01AI068632 (1), UM1AI068616 (1), UM1AI068632 (1), UM1AI106716 (1)